Accessibility Menu
Ansell logo

Ansell(ASX) ANN

Market CapA$4.87BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)+294%
5 Year-2%
1 Year+14%
1 Month+9%
A$34.90
-1.05%
-0.37Today
Ansell last closing stock price
MetricPriceDate
Last closeAUD 34.902026-08-21
Ansell stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.13%AUD 35.302026-08-14
1 month+8.99%AUD 32.022026-07-22
3 month+32.95%AUD 26.252026-05-22
Year to date+0.83%AUD 34.612025-12-31
1 year+13.57%AUD 30.732025-08-21
3 year+60.35%AUD 21.762023-08-22
5 year-2.48%AUD 35.792021-08-20
Since inception+294.12%AUD 8.861992-01-02

Ansell Financials at a Glance

Market Cap

A$4.87BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$3.92B

Net Income (TTM)

$250.84M

EPS (TTM)

A$1.44

P/E Ratio

24.19

Dividend

A$0.80

Beta (Volatility)

-0.01 (Low)

Price

A$34.90

Volume

698,442

Open

A$35.05

Previous Close

A$34.90

Daily Range

A$34.90 - A$35.44

52-Week Range

A$25.05 - A$37.54

Estimated Earnings Date

Aug 24, 2026

ANN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ansell

Ansell Limited is a global leader in protective equipment, serving diverse industries through innovative solutions. The company operates in two main divisions: Healthcare and Industrial, providing essential products that enhance safety and efficiency across various sectors.

Products and Services
  • Healthcare division offers surgical, examination, and specialized gloves
  • Industrial segment provides hand and chemical protective gear
  • Products cater to sectors like automotive, healthcare, and food processing
Growth Outlook
  • Recent quarterly revenue reached USD 1.045 billion, showing strong demand
  • Healthcare segment continues to expand with increasing global health needs
  • Strategic investments in innovation are expected to drive future growth
Financial Highlights
  • Trailing twelve months (TTM) revenue of USD 4.1 billion reflects solid performance
  • Net income for the latest quarter was USD 90.4 million, indicating profitability
  • Dividend yield stands at 2.53%, appealing for income-focused investors
AI Generated • Jul 27, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

15,724

CEO

Neil I. Salmon

Website

www.ansell.com

Headquarters

Richmond, VIC 3121, AU

ANN Financials

Key Financial Metrics (TTM)

Gross Margin

41.95%

Operating Margin

11.24%

Net Income Margin

6.72%

Return on Equity

7.05%

Return on Capital

3.94%

Return on Assets

4.17%

Earnings Yield

4.13%

Dividend Yield

2.31%

Payout Ratio

53.25%

Stock Overview

Market Cap

A$4.87BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

139.43M

Volume

698.44K

Avg. Volume

389.98K

Financials (TTM)

Gross Profit

$1.59B

Operating Income

$449.34M

EBITDA

$605.74M

Operating Cash Flow

$513.62M

Capital Expenditure

-$123.05M

Free Cash Flow

$390.58M

Cash & ST Invst.

$254.17M

Total Debt

$912.82M

Ansell Performance Analysis

Ansell annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30USD 2,691,490,874N/A
20232023-06-30USD 2,460,367,009-8.6%
20242024-06-30USD 2,470,799,0720.4%
20252025-06-30USD 3,093,273,84425.2%
Ansell sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-306.3%
Q22024-12-3122.2%
Q42025-06-30-0.0%
Q22025-12-312.5%
Ansell annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30USD 1.71N/A
20232023-06-30USD 1.731.6%
20242024-06-30USD 0.90-48.0%
20252025-06-30USD 1.0719.0%
Ansell sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30186.7%
Q22024-12-31-11.6%
Q42025-06-30-13.2%
Q22025-12-3187.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$1.05B

+33.2%

Gross Profit

$426.80M

+42.9%

Gross Margin

40.82%

N/A

Market Cap

A$4.87BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$324.40K

N/A

Employees

15,000

N/A

Net Income

$90.43M

+366.1%

EBITDA

$181.78M

+76.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$254.17M

+53.9%

Total Debt

$912.82M

+80.7%

Accounts Receivable

$230.06M

+16.1%

Inventory

$577.59M

+17.9%

Long Term Debt

$830.66M

+114.8%

Short Term Debt

$82.16M

-30.6%

Return on Assets

4.17%

N/A

Return on Invested Capital

8.12%

N/A

Free Cash Flow

$107.34M

+40.5%

Operating Cash Flow

$136.36M

+19.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TLX.AXTelix Pharmaceuticals Limited
A$15.62-10.13%
EBO.AXEbos Group Limited
A$18.96-3.17%
MSB.AXMesoblast Limited
A$2.36-5.98%
NEU.AXNeuren Pharmaceuticals Limited
A$22.46-2.94%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.77+0.10%
IBITiShares Bitcoin Trust
$43.68+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$10.41+0.06%
MARAMara Holdings
$11.26+0.01%

Questions About ANN

What is the current price of Ansell?

Ansell is trading at A$34.90 per share.

What is the 52-week range for Ansell?

Over the past 52 weeks, Ansell has traded between A$25.05 and A$37.54.

How much debt does Ansell have?

As of the most recent reporting period, Ansell reported total debt of $1.23B.

How much cash does Ansell have on hand?

Ansell reported $363.62M in cash and cash equivalents in its most recent financial results.

What is Ansell’s dividend yield?

Ansell currently has a dividend yield of 2.31%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services